A P234KY amino acid replacement has been introduced into GlyRSUAS.Tag:HA.
P32KYmutation. Mutation in analogous codon in human GARS implicated in Charcot-Marie-Tooth disease, type 2D; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.
Analogous to a disease variant in mouse.
Scer\GAL41032.hx Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 escapers (raised at 25[o]C) fail to expand their wings.
Scer\GAL41032.hx, Scer\GAL4elav.PU, Scer\GAL4how-24B or Scer\GAL4Mhc.PU-mediated expression results in reduced larval muscle contractions. This is seen when larvae are raised at 20 or 25o[C] in all cases except Scer\GAL4elav.PU, where the effect is only seen at 25[o]C.
Scer\GAL41032.hx-mediated expression results in reduced bouton number and increased bouton size at larval neuromuscular junctions. Scer\GAL4how-24B or Scer\GAL4Mhc.PU-mediated, but not Scer\GAL4elav.PU-mediated expression also reduces bouton number. Synaptic denervation and axon degeneration are also apparent in these animals. No gross changes in muscle size or structure are observed.
Ubiquitous expression of Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of either a strong Act5C driver (the P{Act5C-GAL4}25FO1 insertion of Scer\GAL4Act5C.PI) or a weaker one (P{Act5C-GAL4}17bFO1) induces lethality at the first instar larval stage and no adult flies emerge. Expression in the nervous system under the control of Scer\GAL4nSyb.PS reach the late stage of pupal development.
Flies expressing Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4OK307 exhibit defects in the Giant Fibre-Trochanteral-Motoneuron-Tergotrochanteral Muscle (GF-TTMn-TTM) circuit. Upon GF stimulation, 40% of recordings show complete absence of the TTM response. In the remaining 60% of recordings, response latencies are severely increased compared to controls. Following frequencies after a train of stimulations at 100 Hz are significantly reduced compared to wild type. Neither presynaptic expression under the control of Scer\GAL4c42.2, or post-synaptic (Scer\GAL4shakB.lethal.4.1) significantly affects the response latency, but the ability of the GF-TTMn to TTM pathway to follow repetitive stimulations is significantly reduced to ~50% using either GAL4 line.
Giant Fibre neuron morphology is disrupted in flies expressing Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4OK307. The synaptic terminal is abnormally thin and the axon as well as the synaptic terminal contains prominent vacuoles. Levels of cell death are similar to controls, and the neurons of the GF circuit are present in all animals.
Expression of Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PU causes a mild rough eye phenotype.
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has visible phenotype, enhanceable by corollad01774, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has visible phenotype, enhanceable by CG15599EY06842, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by lncRNA:CR43132EY02909, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU is an enhancer of visible phenotype of Scer\GAL4GMR.PU, corollad01774
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has eye phenotype, enhanceable by corollad01774, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has eye phenotype, enhanceable by CG15599EY06842, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by lncRNA:CR43132EY02909, Scer\GAL4GMR.PU
GlyRSP234KY.UAS.Tag:HA, Scer\GAL4GMR.PU is an enhancer of eye phenotype of Scer\GAL4GMR.PU, corollad01774
Co-expression of one copy each of CG8316d01774 and Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PU enhances the rough eye phenotype seen when either transgene is expressed alone.
One copy of CG15599EY06842 enhances the rough eye phenotype seen when Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 is expressed under the control of Scer\GAL4GMR.PU.
One copy of CR43132EY02909 does not enhance the rough eye phenotype seen when Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 is expressed under the control of Scer\GAL4GMR.PU.